July 11, 2017

Licensing agreement of ThioBridge™ signed with Abzena (AIM: ABZA)

[…]
June 1, 2017

OBI Pharma Announces Acquisition of TH-3424 from Threshold Pharmaceuticals

[…]
January 25, 2017

China FDA approves Clinical Trial Application for Adagloxad Simolenin Phase III Study

[…]